Comparative Pharmacology
Head-to-head clinical analysis: BIPHETAMINE 20 versus RYKINDO.
Peer-Reviewed Evidence
Head-to-head clinical analysis: BIPHETAMINE 20 versus RYKINDO.
BIPHETAMINE 20 vs RYKINDO
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Biphetamine 20 is a fixed-dose combination of amphetamine and dextroamphetamine, which are non-catecholamine sympathomimetic amines that promote the release of dopamine and norepinephrine from presynaptic neurons, and inhibit their reuptake, thereby increasing synaptic concentrations of these neurotransmitters in the central nervous system.
RYKINDO (pitolisant) is a selective histamine H3 receptor antagonist/inverse agonist. It enhances the activity of brain histaminergic neurons by blocking H3 autoreceptors, thereby increasing histamine release. This promotes wakefulness and reduces excessive daytime sleepiness.
10-20 mg orally once daily in the morning; may increase to 20 mg twice daily (morning and noon) if needed.
10 mg orally once daily, increased to 20 mg orally once daily after 1 week if tolerated, with a maximum of 20 mg/day.
None Documented
None Documented
0.5–1.5 hours for the immediate-release component; terminal elimination half-life of the total amphetamine salts is approximately 10–13 hours in adults
Terminal elimination half-life of risperidone is approximately 3-6 hours, and for 9-hydroxyrisperidone (paliperidone) 21-30 hours in extensive metabolizers. With the long-acting formulation, effective half-life for the release profile is 3-6 days due to slow absorption from gluteal muscle.
Renal (90% as unchanged drug and metabolites, with approximately 30% unchanged); fecal (10%)
RYKINDO (risperidone long-acting injectable) is primarily excreted via urine (70%) as active moiety (risperidone and 9-hydroxyrisperidone), with approximately 14% excreted in feces. Renal clearance accounts for ~60% of total clearance.
Category C
Category C
Central Nervous System Stimulant
Central Nervous System Stimulant